174 related articles for article (PubMed ID: 24066941)
1. Assessing tumor contrast in radiographically dense breast tissue using Diffuse Optical Spectroscopic Imaging (DOSI).
Leproux A; Durkin A; Compton M; Cerussi AE; Gratton E; Tromberg BJ
Breast Cancer Res; 2013; 15(5):R89. PubMed ID: 24066941
[TBL] [Abstract][Full Text] [Related]
2. Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy.
O'Sullivan TD; Leproux A; Chen JH; Bahri S; Matlock A; Roblyer D; McLaren CE; Chen WP; Cerussi AE; Su MY; Tromberg BJ
Breast Cancer Res; 2013 Feb; 15(1):R14. PubMed ID: 23433249
[TBL] [Abstract][Full Text] [Related]
3. Sample size and power determination when limited preliminary information is available.
McLaren CE; Chen WP; O'Sullivan TD; Gillen DL; Su MY; Chen JH; Tromberg BJ
BMC Med Res Methodol; 2017 Apr; 17(1):75. PubMed ID: 28446127
[TBL] [Abstract][Full Text] [Related]
4. Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens.
Tank A; Peterson HM; Pera V; Tabassum S; Leproux A; O'Sullivan T; Jones E; Cabral H; Ko N; Mehta RS; Tromberg BJ; Roblyer D
Breast Cancer Res; 2020 Mar; 22(1):29. PubMed ID: 32169100
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer differential diagnosis using diffuse optical spectroscopic imaging and regression with z-score normalized data.
Cochran JM; Leproux A; Busch DR; O'Sullivan TD; Yang W; Mehta RS; Police AM; Tromberg BJ; Yodh AG
J Biomed Opt; 2021 Feb; 26(2):. PubMed ID: 33624457
[TBL] [Abstract][Full Text] [Related]
6. Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.
Cerussi AE; Tanamai VW; Hsiang D; Butler J; Mehta RS; Tromberg BJ
Philos Trans A Math Phys Eng Sci; 2011 Nov; 369(1955):4512-30. PubMed ID: 22006904
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of breast masses in South Korean premenopausal women using diffuse optical spectroscopic imaging.
Leproux A; Kim YM; Min JW; McLaren CE; Chen WP; O'Sullivan TD; Lee SH; Chung PS; Tromberg BJ
J Biomed Opt; 2016 Jul; 21(7):74001. PubMed ID: 27436049
[TBL] [Abstract][Full Text] [Related]
8. The connecticut experiments second year: ultrasound in the screening of women with dense breasts.
Weigert J; Steenbergen S
Breast J; 2015; 21(2):175-80. PubMed ID: 25683369
[TBL] [Abstract][Full Text] [Related]
9. The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.
Olson JE; Sellers TA; Scott CG; Schueler BA; Brandt KR; Serie DJ; Jensen MR; Wu FF; Morton MJ; Heine JJ; Couch FJ; Pankratz VS; Vachon CM
Breast Cancer Res; 2012 Nov; 14(6):R147. PubMed ID: 23152984
[TBL] [Abstract][Full Text] [Related]
10. Assessing the future of diffuse optical imaging technologies for breast cancer management.
Tromberg BJ; Pogue BW; Paulsen KD; Yodh AG; Boas DA; Cerussi AE
Med Phys; 2008 Jun; 35(6):2443-51. PubMed ID: 18649477
[TBL] [Abstract][Full Text] [Related]
11. Misclassification of Breast Imaging Reporting and Data System (BI-RADS) Mammographic Density and Implications for Breast Density Reporting Legislation.
Gard CC; Aiello Bowles EJ; Miglioretti DL; Taplin SH; Rutter CM
Breast J; 2015; 21(5):481-9. PubMed ID: 26133090
[TBL] [Abstract][Full Text] [Related]
12. The association between breast tissue optical content and mammographic density in pre- and post-menopausal women.
Blackmore KM; Knight JA; Walter J; Lilge L
PLoS One; 2015; 10(1):e0115851. PubMed ID: 25590139
[TBL] [Abstract][Full Text] [Related]
13. Performance assessment of diffuse optical spectroscopic imaging instruments in a 2-year multicenter breast cancer trial.
Leproux A; O'Sullivan TD; Cerussi A; Durkin A; Hill B; Hylton N; Yodh AG; Carp SA; Boas D; Jiang S; Paulsen KD; Pogue B; Roblyer D; Yang W; Tromberg BJ
J Biomed Opt; 2017 Dec; 22(12):121604. PubMed ID: 29389104
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric monitoring of chemotherapy treatment response in locally advanced breast cancer using quantitative ultrasound and diffuse optical spectroscopy.
Tran WT; Childs C; Chin L; Slodkowska E; Sannachi L; Tadayyon H; Watkins E; Wong SL; Curpen B; El Kaffas A; Al-Mahrouki A; Sadeghi-Naini A; Czarnota GJ
Oncotarget; 2016 Apr; 7(15):19762-80. PubMed ID: 26942698
[TBL] [Abstract][Full Text] [Related]
15. Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case-control study with digital mammography.
Keller BM; Chen J; Daye D; Conant EF; Kontos D
Breast Cancer Res; 2015 Aug; 17():117. PubMed ID: 26303303
[TBL] [Abstract][Full Text] [Related]
16. Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging.
Tromberg BJ; Zhang Z; Leproux A; O'Sullivan TD; Cerussi AE; Carpenter PM; Mehta RS; Roblyer D; Yang W; Paulsen KD; Pogue BW; Jiang S; Kaufman PA; Yodh AG; Chung SH; Schnall M; Snyder BS; Hylton N; Boas DA; Carp SA; Isakoff SJ; Mankoff D;
Cancer Res; 2016 Oct; 76(20):5933-5944. PubMed ID: 27527559
[TBL] [Abstract][Full Text] [Related]
17. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.
Melnikow J; Fenton JJ; Whitlock EP; Miglioretti DL; Weyrich MS; Thompson JH; Shah K
Ann Intern Med; 2016 Feb; 164(4):268-78. PubMed ID: 26757021
[TBL] [Abstract][Full Text] [Related]
18. Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
Ueda S; Yoshizawa N; Shigekawa T; Takeuchi H; Ogura H; Osaki A; Saeki T; Ueda Y; Yamane T; Kuji I; Sakahara H
J Nucl Med; 2016 Aug; 57(8):1189-95. PubMed ID: 26940765
[TBL] [Abstract][Full Text] [Related]
19. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS.
Jeffers AM; Sieh W; Lipson JA; Rothstein JH; McGuire V; Whittemore AS; Rubin DL
Radiology; 2017 Feb; 282(2):348-355. PubMed ID: 27598536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
